StocksAstraZenecaAZN.L

AZN.L

AstraZeneca

10498.54 253.77 (2.48%)
Prices By Xignite, in GBX Market Closed
Trade
S
10498.54
B
10521.46

Overview

Prev Close10498.54
Day's Range 10298.72 - 10568.48
52 Week Range 7861.92 - 10988.10
Average Volume (3m)2.15M
1-Year Return29.49%
Beta0.019
Market Cap162.6B
P/E Ratio548.95
Revenue30.52B
EPS-0.4822
Dividend (Yield)2.101 (2.00%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.708/12/202118/02/202203/05/20228500.009000.009500.0010000.0010500.0011000.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Pascal Soriot, MBA, DVM
Employees 83,100

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, AstraZeneca's revenues decreased by 4.69% and amounted to 8.49B. Net income increased by 212.70% to 289.33M. Net assets decreased by NaN to 27.61B and EPS decreased from N/A to 0.18.
AZN.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.32%
Net Profit Margin
8.09%
Operating Margin
5.33%
Return On Investment
6.45%
06/21
09/21
12/21
03/22
Total Revenue
5.88B
7.16B
8.91B
8.49B
Gross Profit
4.32B
3.65B
4.59B
5.15B
Operating Income
764.36M
-72.58M
N/A
637.57M
Net Income
393.26M
-1.2B
-256.73M
289.33M